EW vs PLUS
Edwards Lifesciences Corp (EW) versus ePlus inc (PLUS) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
ePlus inc (PLUS) is a software - application company listed on NASDAQ.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported PLUS revenue for 2025-03-31 was $2.07B. Net income was $108.0M. Revenue was down 7.0% from 2024-03-31 to 2025-03-31. PLUS currently screens at market cap $2.10B and trailing P/E 17.1.
EW currently screens at market cap $49.91B and trailing P/E 46.9. PLUS currently screens at market cap $2.10B and trailing P/E 17.1.
Not investment advice. Open the EW and PLUS stock pages for the full models.
Not investment advice.